Items where authors include "Sha, C"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 8.

Article

Davies, AJ, Barrans, S, Stanton, L et al. (20 more authors) (2023) Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up. Journal of Clinical Oncology, 41 (15). pp. 2718-2723. ISSN 0732-183X

Bewicke-Copley, F, Korfi, K, Araf, S et al. (33 more authors) (2023) Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma. Blood Advances, 7 (5). pp. 845-855. ISSN 2473-9529

Ahmed, S orcid.org/0000-0003-4912-746X, Glover, P, Taylor, J et al. (8 more authors) (2021) Comparative analysis of gene expression platforms for cell‐of‐origin classification of diffuse large B‐cell lymphoma shows high concordance. British Journal of Haematology, 192 (3). bjh.17246. pp. 599-604. ISSN 0007-1048

Cucco, F, Barrans, S, Sha, C et al. (21 more authors) (2020) Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit. Leukemia, 34. pp. 1329-1341. ISSN 0887-6924

Painter, D, Barrans, S, Lacy, S et al. (8 more authors) (2019) Cell‐of‐origin in diffuse large B‐cell lymphoma: findings from the UK's population‐based Haematological Malignancy Research Network. British Journal of Haematology, 185 (4). pp. 781-784. ISSN 0007-1048

Davies, A, Cummin, TE, Barrans, S et al. (21 more authors) (2019) Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial. The Lancet Oncology, 20 (5). pp. 649-662. ISSN 1470-2045

Sha, C, Barrans, S, Cucco, F et al. (20 more authors) (2019) Molecular high-grade B cell lymphoma: defining a poor risk group requiring different approaches to therapy. Journal of Clinical Oncology, 37 (3). pp. 202-213. ISSN 0732-183X

Sha, C, Barrans, S, Care, MA et al. (4 more authors) (2015) Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas. Genome Medicine: medicine in the post-genomic era, 7. 64. ISSN 1756-994X

This list was generated on Sun Mar 24 18:14:15 2024 GMT.